Robert A. Figlin - Profile and Journalist Details

Find journalists that align with your industry, location and vision. Unlock Robert A. Figlin's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.

Get connected with journalists today
Robert A. Figlin

Robert A. Figlin

Verified

Editor-in-Chief, Oncology News Central

Final Covers

infectious diseases, gastroenterology, nephrology clinical research, radiology, pulmonary diseaseHematology-oncology, neurology, psychiatry rheumatology, cardiology

Doesn’t Cover

General news

Journalist Type

-

Seniority Positions

Medium Formats

-

Content

Total articles 54

  • “Second-Line ER-Positive Breast Cancer Has Just Become Very Complicated”

    By Youssef Rddad Verified, Manali Bhave, Robert A. Figlin Verified, Stephanie Graff

    Apr. 15, 2025

  • Will Generational Divide Among Oncologists Affect How AI Changes Cancer Care?

    By Debra Patt, Robert A. Figlin Verified

    Apr. 08, 2025

  • “Second-Line ER-Positive Breast Cancer Has Just Become Very Complicated”

    By Youssef Rddad Verified, Manali Bhave, Robert A. Figlin Verified, Stephanie Graff

    Apr. 15, 2025

As seen in

Company Info

Oncology News Central

Oncology News Central (ONC) is a digital media outlet focused on providing high-quality information for oncology professionals. Rebranded from OBR Oncology in May 2024, ONC is part of HealthCentral Corp. and aims to improve patient outcomes by delivering comprehensive news and insights tailored to the oncology community. The platform offers a range of services, including breaking clinical news, updates on drug approvals, and detailed coverage of major oncology conferences. It features expert commentary from leading oncologists, educational resources like drug monographs and calculators, and tools related to coding and reimbursement. ONC also provides newsletters and podcasts to keep healthcare providers informed about the latest developments in oncology. Its primary audience includes oncologists and healthcare professionals involved in cancer care, supported by an editorial board of recognized leaders in the field.

United States, , United States

+1 415-332-3327

Founded: 2006